Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 3.1T | 3.3T | 2.7T | 2.5T |
| Cost of revenue | 2.7T | 2.9T | 2.6T | 2.5T |
| Gross profit | 422.3B | 339.0B | 133.0B | 76.8B |
| Operating expense | ||||
| Research & development | 10.6B | 17.4B | 17.2B | 14.6B |
| Selling general and admin | 77.8B | 64.8B | 52.2B | 42.2B |
| Other operating expenses | -19.7B | -550M | -31M | 63M |
| Operating income | 278.3B | 169.6B | 25.6B | -9.7B |
| Non operating interest income | ||||
| Income | 18.0B | -1.9B | 19.2B | 24.4B |
| Expense | 51.5B | 31.0B | 51.8B | 50.7B |
| Other income expense | — | — | — | — |
| Pretax income | 217.2B | 225.2B | -72.9B | -25.2B |
| Tax provision | 1.5B | -354.2B | 1.9B | 2.2B |
| Net income | 215.7B | 579.4B | -74.8B | -27.4B |
| Basic EPS | 685 | — | -263 | -109 |
| Diluted EPS | 591 | — | -263 | -109 |
| Basic average shares | 314.9M | — | 284.7M | 252.5M |
| Diluted average shares | 365.0M | — | 365.3M | 362.1M |
| EBITDA | 330.0B | 305.6B | 16.6B | 93.5B |
| Net income from continuing op. | 215.7B | 579.4B | -74.8B | -27.4B |
| Minority interests | -32.3M | 67.4M | -38.4M | -136.8M |
| Preferred stock dividends | — | — | — | — |